News

Filter

Current filters:

bevacizumab

1 to 9 of 335 results

Idera gets $4.3 million clinical milestone under its cancer drug deal with Merck KGaA

20-01-2010

Massachusetts, USA-based Idera Pharmaceuticals says it has achieved a milestone of 3 million euros ($4.3…

AvastinbevacizumabcetuximabErbituxerlotinibLicensingMerck KGaAOncologyPharmaceuticalTarceva

NICE rejects Roche’s bowel cancer drug Avastin for a second time

27-11-2009

Having given it the cold shoulder three years ago, Britain’s healthcare cost effectiveness watchdog…

AvastinbevacizumabcapecitabineEuropeHealthcareOncologyPharmaceuticalRocheXeloda

1 to 9 of 335 results

COMPANY SPOTLIGHT

Menarini

Back to top